Literature DB >> 2931377

Visceral leishmaniasis in congenic mice of susceptible and resistant phenotypes: T-lymphocyte-mediated immunosuppression.

A D Nickol, P F Bonventre.   

Abstract

This paper continues a comparative study (A. D. Nickol and P. F. Bonventre, Infect. Immun. 50:160-168, 1985) describing immune responses exhibited by congenic, Lshs mouse strains C57B1/10 (cure) and B10.D2 (noncure) during the course of disseminated leishmaniasis. We report that sublethal whole-body irradiation of B10.D2 mice before challenge with Leishmania donovani converted the noncuring mice to a curing phenotype. Splenic lymphocytes from L. donovani-infected B10.D2 mice failed to proliferate in response to parasite antigen stimulation in vitro. Splenic lymphocytes from irradiated, cured B10.D2 mice regained the capacity to respond to the parasite antigen stimulus. Transfer of T cells but not B cells from L. donovani-infected B10.D2 mice prevented the acquisition of immunity and recovery from infection in X-irradiated mice. In addition, a splenic T-cell population from L. donovani-infected B10.D2 mice suppressed the proliferation in vitro of parasite antigen-stimulated lymphocytes of irradiation-cured B10.D2 mice. Suppressor T cells were not demonstrable in the spleens of spontaneously cured C57B1/10 mice. Splenic lymphocytes from infected B10.D2 mice were deficient in the production of macrophage-activating factor (MAF) upon stimulation by L. donovani antigens in vitro. Deficient MAF production was specific for parasite antigen stimulation, because MAF production subsequent to concanavalin A stimulation of splenic lymphocytes from infected B10.D2 mice was not suppressed. The data suggest that a genetically based immunological defect in B10.D2 mice prevents the acquisition of effective cell-mediated immunity and subsequent elimination of L. donovani from tissue macrophages. The immunological deficit, not apparent in the curing C57B1/10, appears to be caused by the development of parasite antigen-specific suppressor T cells during the course of the disseminated leishmaniasis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2931377      PMCID: PMC262152          DOI: 10.1128/iai.50.1.169-174.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Regulation of the immune response to tumor antigens. II. The nature of immunosuppressor cells in tumor-bearing hosts.

Authors:  S Fujimoto; M I Greene; A H Sehon
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

2.  Production of migration inhibitory factor by non-dividing lymphocytes.

Authors:  R E Rocklin
Journal:  J Immunol       Date:  1973-03       Impact factor: 5.422

3.  Antibody response after immunisation with typhoid-paratyphoid A and B vaccine in kala-azar.

Authors:  C Cassimos; S Lazanakis; T Thomaidis
Journal:  Acta Paediatr Scand       Date:  1966-05

4.  Leukocyte migration inhibitory factor (LMIF) induced by concanavalin A: standardized microassay for production in vitro.

Authors:  A J Górski; B Dupont; J A Hansen; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

5.  Inhibition of tumor growth in syngeneic chimeric mice mediated by a depletion of suppressor T cells.

Authors:  V Rotter; N Trainin
Journal:  Transplantation       Date:  1975-07       Impact factor: 4.939

6.  T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor.

Authors:  M J Berendt; R J North
Journal:  J Exp Med       Date:  1980-01-01       Impact factor: 14.307

7.  Regulation of the immune response to tumor antigen. IV. Tumor antigen-specific suppressor factor(s) bear I-J determinants and induce suppressor T cells in vivo.

Authors:  L L Perry; B Benacerraf; M I Greene
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

8.  Regulation of the immune response to tumor antigen. VI. Differential specificities of suppressor T cells or their products and effector T cells.

Authors:  M I Greene; L L Perry
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

9.  Enhancing T lymphocytes from tumor-bearing mice suppress host resistance to a syngeneic tumor.

Authors:  A J Treves; C Carnaud; N Trainin; M Feldman; I R Cohen
Journal:  Eur J Immunol       Date:  1974-11       Impact factor: 5.532

10.  Regression and inhibition of sarcoma growth by interference with a radiosensitive T-cell population.

Authors:  K E Hellström; I Hellström; J A Kant; J D Tamerius
Journal:  J Exp Med       Date:  1978-09-01       Impact factor: 14.307

View more
  7 in total

1.  Acquisition of cell-mediated immunity to Leishmania. I. Primary T-cell activation detected by IL-2 receptor expression.

Authors:  P M Kaye
Journal:  Immunology       Date:  1987-07       Impact factor: 7.397

2.  Protective efficacy and immunogenicity of Escherichia coli K13 diphtheria toxoid conjugate against experimental ascending pyelonephritis.

Authors:  Varinder Kumar; N k Ganguly; Kusum Joshi; Rahul Mittal; Kusum Harjai; Sanjay Chhibber; Saroj Sharma
Journal:  Med Microbiol Immunol       Date:  2005-05-21       Impact factor: 3.402

3.  Characterization of Leishmania isolates from Nepalese patients with visceral leishmaniasis.

Authors:  Kishor Pandey; Testuo Yanagi; Basu Dev Pandey; Arun Kumar Mallik; Jeevan Bahadur Sherchand; Hiroji Kanbara
Journal:  Parasitol Res       Date:  2007-02-20       Impact factor: 2.289

4.  Visceral leishmaniasis in congenic mice of susceptible and resistant phenotypes: immunosuppression by adherent spleen cells.

Authors:  A D Nickol; P F Bonventre
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

5.  Kinetics of cell-mediated immunity developing during the course of Leishmania major infection in 'healer' and 'non-healer' mice: progressive impairment of response to and generation of interleukin-2.

Authors:  W Solbach; M Lohoff; H Streck; P Rohwer; M Röllinghoff
Journal:  Immunology       Date:  1987-11       Impact factor: 7.397

6.  Presence of a macrophage-mediated suppressor cell mechanism during cell-mediated immune response in experimental visceral leishmaniasis.

Authors:  H W Murray; S M Carriero; D M Donelly
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

7.  Cytokines and splenic remodelling during Leishmania donovani infection.

Authors:  Marcela Montes de Oca; Christian R Engwerda; Paul M Kaye
Journal:  Cytokine X       Date:  2020-09-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.